应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMNN Imunon, Inc.
交易中 07-14 13:06:47 EDT
0.5540
-0.0511
-8.44%
最高
0.6050
最低
0.5500
成交量
104.45万
今开
0.6000
昨收
0.6051
日振幅
9.09%
总市值
1,180万
流通市值
982.55万
总股本
2,130万
成交额
59.54万
换手率
5.89%
流通股本
1,774万
市净率
26.11
ROE
-397.54%
每股收益
-1.39
52周最高
3.65
52周最低
0.3700
市盈率
-0.40
股息
0.00
股息收益率
0.00
ROA
-107.77%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Imunon, Inc.盘中异动 下午盘股价大跌5.34%
市场透视 · 07-10
Imunon, Inc.盘中异动 下午盘股价大跌5.34%
Imunon, Inc.盘中异动 早盘大幅下跌5.66%
市场透视 · 06-30
Imunon, Inc.盘中异动 早盘大幅下跌5.66%
Imunon, Inc.6月25日成交额为86.72万美元
市场透视 · 06-26
Imunon, Inc.6月25日成交额为86.72万美元
Imunon, Inc.6月24日成交额为87.64万美元
市场透视 · 06-25
Imunon, Inc.6月24日成交额为87.64万美元
Imunon, Inc.盘中异动 早盘股价大跌5.88%报0.960美元
市场透视 · 06-23
Imunon, Inc.盘中异动 早盘股价大跌5.88%报0.960美元
Imunon, Inc.6月20日成交额为132.65万美元
市场透视 · 06-21
Imunon, Inc.6月20日成交额为132.65万美元
Imunon, Inc.6月17日成交额为135.34万美元
市场透视 · 06-18
Imunon, Inc.6月17日成交额为135.34万美元
Imunon, Inc.盘中异动 早盘股价大跌7.94%
市场透视 · 06-16
Imunon, Inc.盘中异动 早盘股价大跌7.94%
Imunon, Inc.6月13日成交额为230.17万美元
市场透视 · 06-14
Imunon, Inc.6月13日成交额为230.17万美元
Imunon, Inc.6月11日成交额为431.46万美元
市场透视 · 06-12
Imunon, Inc.6月11日成交额为431.46万美元
Imunon, Inc.6月10日成交额为2130.94万美元
市场透视 · 06-11
Imunon, Inc.6月10日成交额为2130.94万美元
Imunon, Inc.盘中异动 早盘股价大跌5.48%
市场透视 · 06-09
Imunon, Inc.盘中异动 早盘股价大跌5.48%
Imunon, Inc.6月6日成交额为702.67万美元
市场透视 · 06-07
Imunon, Inc.6月6日成交额为702.67万美元
Imunon, Inc.6月4日成交额为918.70万美元
市场透视 · 06-05
Imunon, Inc.6月4日成交额为918.70万美元
Imunon, Inc.盘中异动 股价大涨5.18%
市场透视 · 06-03
Imunon, Inc.盘中异动 股价大涨5.18%
Imunon, Inc.盘中异动 股价大涨12.45%
市场透视 · 06-02
Imunon, Inc.盘中异动 股价大涨12.45%
Imunon, Inc.盘中异动 股价大涨16.08%
市场透视 · 05-30
Imunon, Inc.盘中异动 股价大涨16.08%
Imunon, Inc.5月28日成交额为4422.89万美元
市场透视 · 05-29
Imunon, Inc.5月28日成交额为4422.89万美元
Imunon, Inc.盘中异动 股价大跌11.21%
市场透视 · 05-27
Imunon, Inc.盘中异动 股价大跌11.21%
Imunon, Inc.5月23日成交额为4.90亿美元
市场透视 · 05-24
Imunon, Inc.5月23日成交额为4.90亿美元
加载失败,点击重试
公司概况
公司名称:
Imunon, Inc.
所属市场:
NASDAQ
上市日期:
2000-05-31
主营业务:
Imunon, Inc.成立于1982年,是一家特拉华州公司。Celsion公司是一家完全集成的肿瘤药物开发公司,致力于开发创新癌症治疗,包括化学疗法执导,免疫治疗和RNA-或DNA为基础的治疗组合。该公司的首席程序是ThermoDox,多柔比星的专利热活化脂质体封装,目前处于III期临床试验为原发性肝癌的治疗(OPTIMA研究)和II期临床试验复发治疗胸壁乳腺癌(DIGNITY研究)。其管道还包括GEN-1(原名EGEN-001),基于DNA的免疫治疗的卵巢癌和脑癌的局部治疗。该公司有三个平台技术为治疗的发展对于那些难以治疗的癌症,新型核酸为基础的免疫疗法等抗癌DNA或RNA疗法,包括TheraPlas和TheraSilence。从2014年上半年开始,正在对产品ThermoDox进行针对原发性肝癌的III期临床试验(OPTIMA研究)和针对复发性胸壁乳腺癌的II期临床试验(DIGNITY研究)。
发行价格:
--
{"stockData":{"symbol":"IMNN","market":"US","secType":"STK","nameCN":"Imunon, Inc.","latestPrice":0.554,"timestamp":1752512805216,"preClose":0.6051,"halted":0,"volume":1044530,"delay":0,"floatShares":17735600,"shares":21303358,"eps":-1.390339,"marketStatus":"交易中","change":-0.0511,"latestTime":"07-14 13:06:45 EDT","open":0.6,"high":0.605,"low":0.55,"amount":595390.978505,"amplitude":0.090894,"askPrice":0.5644,"askSize":700,"bidPrice":0.553,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-1.390339,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752523200000},"marketStatusCode":2,"adr":0,"listingDate":959745600000,"exchange":"NASDAQ","adjPreClose":0.6051,"preHourTrading":{"tag":"盘前","latestPrice":0.6098,"preClose":0.6051,"latestTime":"09:29 EDT","volume":39635,"amount":24111.413214,"timestamp":1752499746953},"postHourTrading":{"tag":"盘后","latestPrice":0.59995,"preClose":0.6051,"latestTime":"19:56 EDT","volume":69407,"amount":41681.9029,"timestamp":1752278201920},"volumeRatio":2.097823},"requestUrl":"/m/hq/s/IMNN/tweets","defaultTab":"tweets","newsList":[{"id":"2550678107","title":"Imunon, Inc.盘中异动 下午盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550678107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550678107?lang=zh_cn&edition=full","pubTime":"2025-07-11 02:08","pubTimestamp":1752170924,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日02时08分,Imunon, Inc.股票出现波动,股价快速下跌5.34%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.94%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711020844953dbbec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711020844953dbbec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2547101871","title":"Imunon, Inc.盘中异动 早盘大幅下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547101871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547101871?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:00","pubTimestamp":1751292059,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时00分,Imunon, Inc.股票出现波动,股价大幅下挫5.66%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630220100a7265124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630220100a7265124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2546827148","title":"Imunon, Inc.6月25日成交额为86.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546827148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546827148?lang=zh_cn&edition=full","pubTime":"2025-06-26 10:48","pubTimestamp":1750906133,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日,Imunon, Inc.成交额为86.72万美元,成交额较昨日减少1.05%,当日成交量为101.72万股。Imunon, Inc.于2025年6月25日跌5.85%,报0.836美元,该股过去5个交易日跌26.04%,年初至今跌12.03%,过去60日跌23.33%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626104859a71e0d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626104859a71e0d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2546664622","title":"Imunon, Inc.6月24日成交额为87.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546664622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546664622?lang=zh_cn&edition=full","pubTime":"2025-06-25 10:46","pubTimestamp":1750819565,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,Imunon, Inc.成交额为87.64万美元,成交额较昨日减少36.97%,当日成交量为95.41万股。Imunon, Inc.于2025年6月24日跌3.71%,报0.888美元,该股过去5个交易日跌22.14%,年初至今跌6.57%,过去60日跌22.14%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625104608a71c3293&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625104608a71c3293&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2545736417","title":"Imunon, Inc.盘中异动 早盘股价大跌5.88%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545736417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545736417?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:41","pubTimestamp":1750686092,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时41分,Imunon, Inc.股票出现波动,股价大幅下跌5.88%。截至发稿,该股报0.960美元/股,成交量28.5236万股,换手率1.40%,振幅1.97%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214132978b56f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214132978b56f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2545104360","title":"Imunon, Inc.6月20日成交额为132.65万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545104360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545104360?lang=zh_cn&edition=full","pubTime":"2025-06-21 10:45","pubTimestamp":1750473905,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日,Imunon, Inc.成交额为132.65万美元,成交额较昨日减少66.01%,当日成交量为131.81万股。Imunon, Inc.于2025年6月20日涨2.0%,报1.02美元,该股过去5个交易日跌37.04%,年初至今涨7.37%,过去60日涨2.0%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621104509a4b59f37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621104509a4b59f37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2544459289","title":"Imunon, Inc.6月17日成交额为135.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544459289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544459289?lang=zh_cn&edition=full","pubTime":"2025-06-18 10:45","pubTimestamp":1750214733,"startTime":"0","endTime":"0","summary":"美东时间2025年6月17日,Imunon, Inc.成交额为135.34万美元,成交额较昨日减少67.44%,当日成交量为118.88万股。Imunon, Inc.于2025年6月17日跌0.88%,报1.13美元,该股过去5个交易日跌30.25%,年初至今涨18.95%,过去60日涨18.95%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618104535a4af9a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618104535a4af9a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2543460371","title":"Imunon, Inc.盘中异动 早盘股价大跌7.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543460371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543460371?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:33","pubTimestamp":1750080821,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时33分,Imunon, Inc.股票出现异动,股价大幅下跌7.94%。Imunon, Inc.股票所在的生物技术行业中,整体跌幅为0.54%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213341a4ac334b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213341a4ac334b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2543654708","title":"Imunon, Inc.6月13日成交额为230.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543654708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543654708?lang=zh_cn&edition=full","pubTime":"2025-06-14 10:44","pubTimestamp":1749869066,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日,Imunon, Inc.成交额为230.17万美元,成交额较昨日减少1.96%,当日成交量为157.57万股。Imunon, Inc.于2025年6月13日跌11.73%,报1.43美元,该股过去5个交易日跌2.05%,年初至今涨50.53%,过去60日涨54.26%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614104429a708a2f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614104429a708a2f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2542507875","title":"Imunon, Inc.6月11日成交额为431.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542507875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542507875?lang=zh_cn&edition=full","pubTime":"2025-06-12 10:34","pubTimestamp":1749695692,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日,Imunon, Inc.成交额为431.46万美元,成交额较昨日减少79.75%,当日成交量为262.16万股。Imunon, Inc.于2025年6月11日涨2.47%,报1.66美元,该股过去5个交易日跌2.35%,年初至今涨74.74%,过去60日涨86.52%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612103456a4a447f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612103456a4a447f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2542378526","title":"Imunon, Inc.6月10日成交额为2130.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542378526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542378526?lang=zh_cn&edition=full","pubTime":"2025-06-11 10:24","pubTimestamp":1749608689,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日,Imunon, Inc.成交额为2130.94万美元,成交额较昨日增加688.37%,当日成交量为1200.74万股。Imunon, Inc.于2025年6月10日涨21.8%,报1.62美元,该股过去5个交易日跌15.18%,年初至今涨70.53%,过去60日涨87.28%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611102450a4a2c357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611102450a4a2c357&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2542380112","title":"Imunon, Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542380112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542380112?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:36","pubTimestamp":1749476169,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时36分,Imunon, Inc.股票出现异动,股价快速跳水5.48%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092136099514d557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092136099514d557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0},{"id":"2541979388","title":"Imunon, Inc.6月6日成交额为702.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541979388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541979388?lang=zh_cn&edition=full","pubTime":"2025-06-07 10:22","pubTimestamp":1749262940,"startTime":"0","endTime":"0","summary":"美东时间2025年6月6日,Imunon, Inc.成交额为702.67万美元,成交额较昨日增加26.13%,当日成交量为461.87万股。Imunon, Inc.于2025年6月6日涨4.29%,报1.46美元,该股过去5个交易日跌41.37%,年初至今涨53.68%,过去60日涨65.35%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607102226a6fdd560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607102226a6fdd560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2541701921","title":"Imunon, Inc.6月4日成交额为918.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541701921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541701921?lang=zh_cn&edition=full","pubTime":"2025-06-05 10:22","pubTimestamp":1749090144,"startTime":"0","endTime":"0","summary":"美东时间2025年6月4日,Imunon, Inc.成交额为918.70万美元,成交额较昨日减少53.11%,当日成交量为510.99万股。Imunon, Inc.于2025年6月4日跌10.99%,报1.7美元,该股过去5个交易日涨11.84%,年初至今涨78.95%,过去60日涨91.01%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605102231a6fb094f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605102231a6fb094f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":0},{"id":"2540777836","title":"Imunon, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540777836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540777836?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:31","pubTimestamp":1748957499,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时31分,Imunon, Inc.股票出现波动,股价急速上涨5.18%。Imunon, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213139976ff541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213139976ff541&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":1},{"id":"2540996267","title":"Imunon, Inc.盘中异动 股价大涨12.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540996267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540996267?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:31","pubTimestamp":1748871078,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时31分,Imunon, Inc.股票出现波动,股价大幅上涨12.45%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213119a6f72324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213119a6f72324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":1},{"id":"2539024278","title":"Imunon, Inc.盘中异动 股价大涨16.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539024278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539024278?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:31","pubTimestamp":1748611883,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时31分,Imunon, Inc.股票出现异动,股价急速拉升16.08%。Imunon, Inc.股票所在的生物技术行业中,整体跌幅为2.82%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213123a492eeec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213123a492eeec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":1},{"id":"2539281408","title":"Imunon, Inc.5月28日成交额为4422.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539281408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539281408?lang=zh_cn&edition=full","pubTime":"2025-05-29 10:21","pubTimestamp":1748485295,"startTime":"0","endTime":"0","summary":"美东时间2025年5月28日,Imunon, Inc.成交额为4422.89万美元,成交额较昨日减少74.19%,当日成交量为2348.03万股。Imunon, Inc.于2025年5月28日跌33.04%,报1.52美元,该股过去5个交易日涨243.12%,年初至今涨60.0%,过去60日涨73.91%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529102146a6f124e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529102146a6f124e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":1},{"id":"2538846226","title":"Imunon, Inc.盘中异动 股价大跌11.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538846226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538846226?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:32","pubTimestamp":1748352779,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时32分,Imunon, Inc.股票出现异动,股价急速下挫11.21%。Imunon, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Imunon, Inc.公司简介:Imunon Inc是一家临床阶段的生物技术公司,专注于推进一系列治疗方法,利用人体的自然机制在多种人类疾病中产生安全、有效和持久的反应,从而与传统疗法形成差异化的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213259a6ef03cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213259a6ef03cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMNN"],"gpt_icon":1},{"id":"2537348169","title":"Imunon, Inc.5月23日成交额为4.90亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537348169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537348169?lang=zh_cn&edition=full","pubTime":"2025-05-24 10:09","pubTimestamp":1748052562,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日,Imunon, Inc.成交额为4.90亿美元,成交额较昨日增加4769.35%,当日成交量为4.14亿股。Imunon, Inc.于2025年5月23日涨179.18%,报1.16美元,该股过去5个交易日涨139.67%,年初至今涨22.11%,过去60日涨43.21%。它正在开发其非病毒DNA技术,应用于其多种治疗方式。临床项目IMNN-001是一种基于DNA的免疫疗法,为了在局部治疗卵巢癌,已完成第二阶段临床研究。另外,公司还启动了其COVID-19加强疫苗的首次人体研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524100931a48a55bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524100931a48a55bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMNN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.imunon.com","stockEarnings":[{"period":"1week","weight":-0.2341},{"period":"1month","weight":-0.6355},{"period":"3month","weight":-0.2881},{"period":"6month","weight":-0.3276},{"period":"1year","weight":-0.5769},{"period":"ytd","weight":-0.3631}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Imunon, Inc.成立于1982年,是一家特拉华州公司。Celsion公司是一家完全集成的肿瘤药物开发公司,致力于开发创新癌症治疗,包括化学疗法执导,免疫治疗和RNA-或DNA为基础的治疗组合。该公司的首席程序是ThermoDox,多柔比星的专利热活化脂质体封装,目前处于III期临床试验为原发性肝癌的治疗(OPTIMA研究)和II期临床试验复发治疗胸壁乳腺癌(DIGNITY研究)。其管道还包括GEN-1(原名EGEN-001),基于DNA的免疫治疗的卵巢癌和脑癌的局部治疗。该公司有三个平台技术为治疗的发展对于那些难以治疗的癌症,新型核酸为基础的免疫疗法等抗癌DNA或RNA疗法,包括TheraPlas和TheraSilence。从2014年上半年开始,正在对产品ThermoDox进行针对原发性肝癌的III期临床试验(OPTIMA研究)和针对复发性胸壁乳腺癌的II期临床试验(DIGNITY研究)。","yearOnYearQuotes":[{"month":1,"riseRate":0.424242,"avgChangeRate":0.08883},{"month":2,"riseRate":0.375,"avgChangeRate":0.031658},{"month":3,"riseRate":0.515152,"avgChangeRate":0.050761},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.048439},{"month":5,"riseRate":0.352941,"avgChangeRate":0.12499},{"month":6,"riseRate":0.441176,"avgChangeRate":-0.05147},{"month":7,"riseRate":0.382353,"avgChangeRate":-0.052906},{"month":8,"riseRate":0.424242,"avgChangeRate":0.013026},{"month":9,"riseRate":0.30303,"avgChangeRate":-0.076521},{"month":10,"riseRate":0.30303,"avgChangeRate":-0.041509},{"month":11,"riseRate":0.30303,"avgChangeRate":-0.021904},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.040384}],"exchange":"NASDAQ","name":"Imunon, Inc.","nameEN":"Imunon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Imunon, Inc.(IMNN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Imunon, Inc.(IMNN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Imunon, Inc.,IMNN,Imunon, Inc.股票,Imunon, Inc.股票老虎,Imunon, Inc.股票老虎国际,Imunon, Inc.行情,Imunon, Inc.股票行情,Imunon, Inc.股价,Imunon, Inc.股市,Imunon, Inc.股票价格,Imunon, Inc.股票交易,Imunon, Inc.股票购买,Imunon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Imunon, Inc.(IMNN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Imunon, Inc.(IMNN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}